↓ Skip to main content

CSF β-amyloid is not a prognostic marker in multiple sclerosis patients

Overview of attention for article published in Multiple Sclerosis and Related Disorders, August 2022

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (76th percentile)
  • Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

news
1 news outlet

Readers on

mendeley
13 Mendeley